|
| ■ Bibliografia |
|
|
- Aghemo A, Cologni G, Pasilo L, et al. Safety and efficacy od DAAs in 2432 HCV patients with advanced fibrosis: an interim analysis of the Lombardia Regional Network for Viral Hepatitis. EASL 2016 LBP500
- Rizzardini G, Maggiolo F, D’Ambrosio R, et al. Efficacy of directly acting antivirals in HCV-3 patients with advanced fibrosis: an interim analysis of the Lombardia Regional Network for Viral Hepatitis. ICAR 2016 OC13
- Welzel TM, Petersen J, Herzer K, et al. Daclatasvir plus sofosbuvir with or without ribavirin for treatment of chronic HCV infection in patients with advanced liver disease: results of a European Compassionate Use Programme. EASL 2016 Poster SAT 275
- Puoti M, Aghemo A, D'Ambrosio R, et al. Adherence to EASL recommendations significantly increased treatment response in 872 patients with hepatitis C treated with combinations of oral antivirals. ICAR 2016 OC19
|
